{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "35996283", "DateCompleted": {"Year": "2023", "Month": "03", "Day": "14"}, "DateRevised": {"Year": "2023", "Month": "03", "Day": "14"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": ["10.5588/ijtld.21.0555"], "Journal": {"ISSN": "1815-7920", "JournalIssue": {"Volume": "26", "Issue": "9", "PubDate": {"Year": "2022", "Month": "Sep", "Day": "01"}}, "Title": "The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease", "ISOAbbreviation": "Int J Tuberc Lung Dis"}, "ArticleTitle": "Medicinal plant use and adherence problems to TB treatment.", "Pagination": {"StartPage": "850", "EndPage": "856", "MedlinePgn": "850-856"}, "Abstract": {"AbstractText": ["<b>BACKGROUND:</b> Good adherence is essential in the treatment of TB. The aim of this study was to describe medication consumption patterns and to assess factors associated with adherence to TB treatment among TB patients in Lom\u00e9, Togo.<b>METHODS:</b> A cross-sectional study was conducted among TB patients in 10 health structures in Lom\u00e9 from September 2019 to January 2020. TB patients aged \u226518 years and under treatment for at least 2 months were eligible for this study. Adherence to TB treatment was assessed using the Girerd compliance test.<b>RESULTS:</b> A total of 195 TB patients (61.5% male) with a median age of 35 years (IQR 27-44) were recruited. TB-HIV coinfection was 11.3%. Polypharmacy (\u22655 medications/day) and using medicinal plants were observed in respectively 6.2% and 42.6% of patients. Prevalence of TB treatment adherence problems was 68.2% (95% CI 61.2-74.7). Being <35 years (aOR 2.79; <i>P</i> = 0.005) and taking medicinal plants (aOR 4.31; <i>P</i> < 0.001) were associated with TB treatment adherence problems.<b>CONCLUSION:</b> Treatment adherence problems, a major obstacle to TB elimination, are highly prevalent in TB patients in Lom\u00e9, and were associated with the use of medicinal plants. Reasons for the use of medicinal plants should be documented in order to propose appropriate interventions to reinforce adherence to TB treatment."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "D\u00e9partement de Sant\u00e9 Publique, Facult\u00e9 des Sciences de la Sant\u00e9, Universit\u00e9 de Lom\u00e9, Lom\u00e9, Togo, Centre Africain de Recherche en Epid\u00e9miologie et en Sant\u00e9 Publique (CARESP), Lom\u00e9, Togo."}], "LastName": "Gbeasor-Komlanvi", "ForeName": "F A", "Initials": "FA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "D\u00e9partement de Sant\u00e9 Publique, Facult\u00e9 des Sciences de la Sant\u00e9, Universit\u00e9 de Lom\u00e9, Lom\u00e9, Togo, Centre Africain de Recherche en Epid\u00e9miologie et en Sant\u00e9 Publique (CARESP), Lom\u00e9, Togo."}], "LastName": "Sadio", "ForeName": "A J", "Initials": "AJ"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Centre Africain de Recherche en Epid\u00e9miologie et en Sant\u00e9 Publique (CARESP), Lom\u00e9, Togo."}], "LastName": "Adama", "ForeName": "O I", "Initials": "OI"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Centre Africain de Recherche en Epid\u00e9miologie et en Sant\u00e9 Publique (CARESP), Lom\u00e9, Togo."}], "LastName": "Zida-Compaore", "ForeName": "W I C", "Initials": "WIC"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Centre Africain de Recherche en Epid\u00e9miologie et en Sant\u00e9 Publique (CARESP), Lom\u00e9, Togo."}], "LastName": "Tchankoni", "ForeName": "M K", "Initials": "MK"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "D\u00e9partement de M\u00e9decine et Sp\u00e9cialit\u00e9s m\u00e9dicales, Facult\u00e9 des Sciences de la Sant\u00e9, Universit\u00e9 de Lom\u00e9, Lom\u00e9, Togo, Centre Hospitalier Universitaire Sylvanus-Olympio, Service de Pneumo-Phtisiologie, Lom\u00e9, Togo."}], "LastName": "Adjoh", "ForeName": "K S", "Initials": "KS"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Programme National de Lutte contre la Tuberculose, Minist\u00e8re de la Sant\u00e9, de l\u00b4Hygi\u00e8ne Publique et de l\u00b4Acc\u00e8s Universel aux Soins, Lom\u00e9, Togo."}], "LastName": "Dogo", "ForeName": "F", "Initials": "F"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "D\u00e9partement de Sant\u00e9 Publique, Facult\u00e9 des Sciences de la Sant\u00e9, Universit\u00e9 de Lom\u00e9, Lom\u00e9, Togo, Centre Africain de Recherche en Epid\u00e9miologie et en Sant\u00e9 Publique (CARESP), Lom\u00e9, Togo, Bordeaux Population Health Research, Universit\u00e9 de Bordeaux, Unit\u00e9 1219, Institut national de la sant\u00e9 et de la recherche m\u00e9dicale, Institut de Sant\u00e9 Publique d\u00b4Epid\u00e9miologie et de D\u00e9veloppement, Bordeaux, France."}], "LastName": "Ekouevi", "ForeName": "D K", "Initials": "DK"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "France", "MedlineTA": "Int J Tuberc Lung Dis", "NlmUniqueID": "9706389", "ISSNLinking": "1027-3719"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Plant Preparations"}, {"RegistryNumber": "0", "NameOfSubstance": "Antitubercular Agents"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Adult"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Cross-Sectional Studies"}, {"QualifierName": ["epidemiology"], "DescriptorName": "HIV Infections"}, {"QualifierName": [], "DescriptorName": "Medication Adherence"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Prevalence"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Tuberculosis"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Plant Preparations"}, {"QualifierName": ["administration & dosage"], "DescriptorName": "Antitubercular Agents"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2022", "Month": "8", "Day": "23", "Hour": "0", "Minute": "42"}, {"Year": "2022", "Month": "8", "Day": "24", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "8", "Day": "25", "Hour": "6", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["35996283", "10.5588/ijtld.21.0555"]}}], "PubmedBookArticle": []}